Cargando…

Epidemiology and Outcomes of Hospitalizations with Invasive Aspergillosis in the United States, 2010–2013

BACKGROUND: Invasive aspergillosis (IA) complicates the care of up to 13% of patients with varying forms of immune compromise. The accompanying morbidity and mortality associated with IA remains high. We sought to describe the epidemiology and outcomes for all hospitalizations associated with IA in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zilberberg, Marya D, Nathanson, Brian, Harrington, Rachel, Spalding, James, Shorr, Andrew F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632117/ http://dx.doi.org/10.1093/ofid/ofx163.047

Ejemplares similares

Time Trends in the Burden of Hospitalizations with Invasive Aspergillosis in the United States, 2004–2013
por: Zilberberg, Marya D, et al.
Publicado: (2017)

Burden of hospitalizations over time with invasive aspergillosis in the United States, 2004–2013
por: Zilberberg, Marya D., et al.
Publicado: (2019)

1455. Epidemiology, Empiric Treatment, and Outcomes Among Hospitalized Patients With Complicated Urinary Tract Infections in the United States, 2013–2018
por: Zilberberg, Marya, et al.
Publicado: (2019)

1461. Antimicrobial Susceptibility Patterns of Common Complicated Urinary Tract Infection Pathogens in US Hospitals, 2013–2018
por: Zilberberg, Marya, et al.
Publicado: (2019)

2259. Predictors of Empiric Carbapenem Therapy in Complicated Intra-Abdominal Infections in the United States, 2013–2017: A Retrospective Cohort Study
por: Zilberberg, Marya, et al.
Publicado: (2019)

Descriptive Epidemiology and Outcomes of Hospitalizations With Complicated Urinary Tract Infections in the United States, 2018
por: Zilberberg, Marya D, et al.
Publicado: (2022)

1314. Descriptive Epidemiology of 30-day Readmissions among Survivors of Hospitalization with Bacterial Nosocomial Pneumonia in the US, 2012-2019
por: Zilberberg, Marya, et al.
Publicado: (2021)

Descriptive Epidemiology and Outcomes of Nonventilated Hospital-Acquired, Ventilated Hospital-Acquired, and Ventilator-Associated Bacterial Pneumonia in the United States, 2012–2019
por: Zilberberg, Marya D., et al.
Publicado: (2021)

1430. Descriptive Epidemiology of Emergency Department Visits with cUTI in the US, 2012-2018
por: Zilberberg, Marya, et al.
Publicado: (2021)

Descriptive epidemiology and outcomes of emergency department visits with complicated urinary tract infections in the United States, 2016–2018
por: Zilberberg, Marya D., et al.
Publicado: (2022)

1420. Descriptive Epidemiology of UTI Hospitalizations in the US, 2018
por: Zilberberg, Marya, et al.
Publicado: (2021)

2817. Outcomes of Timely vs. Delayed Meropenem/Vaborbactam Treatment of Infections with CRE among Adults Hospitalized in the US, 2019-2021
por: Zilberberg, Marya D, et al.
Publicado: (2023)

2816. Comparative Effectiveness of Meropenem/Vaborbactam vs. Ceftazidime/Avibactam among Adults Hospitalized with an Infectious Syndrome in the US, 2019-2021
por: Zilberberg, Marya D, et al.
Publicado: (2023)

Multiple antimicrobial resistance and outcomes among hospitalized patients with complicated urinary tract infections in the US, 2013–2018: a retrospective cohort study
por: Zilberberg, Marya D., et al.
Publicado: (2021)

Inappropriate Empiric Therapy Impacts Complications and Hospital Resource Utilization Differentially Among Different Types of Bacterial Nosocomial Pneumonia: A Cohort Study, United States, 2014–2019
por: Zilberberg, Marya D., et al.
Publicado: (2022)

Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014–2019
por: Zilberberg, Marya D., et al.
Publicado: (2022)

1427. Healthcare Resource Utilization During Hospitalizations with UTI in the US, 2018
por: Zilberberg, Marya, et al.
Publicado: (2021)

Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States
por: Kaye, Keith S, et al.
Publicado: (2019)

Prolonged acute mechanical ventilation and hospital bed utilization in 2020 in the United States: implications for budgets, plant and personnel planning
por: Zilberberg, Marya D, et al.
Publicado: (2008)

Growth and Geographic Variation in Hospitalizations with Resistant Infections, United States, 2000–2005
por: Zilberberg, Marya D., et al.
Publicado: (2008)

Descriptive Epidemiology and Outcomes of Patients with Short Stay Hospitalizations for the Treatment of Congestive Heart Failure in the US
por: Zilberberg, Marya D, et al.
Publicado: (2023)

Increase in Adult Clostridium difficile–related Hospitalizations and Case-Fatality Rate, United States, 2000–2005
por: Zilberberg, Marya D., et al.
Publicado: (2008)

Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis
por: Zilberberg, Marya D., et al.
Publicado: (2016)

Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis
por: Zilberberg, Marya D., et al.
Publicado: (2017)

Daily cost of delay to adequate antibiotic treatment among patients surviving a hospitalization with community-onset Acinetobacter baumannii pneumonia or sepsis
por: Zilberberg, Marya D., et al.
Publicado: (2017)

Hospital readmission with Clostridium difficile infection as a secondary diagnosis is associated with worsened outcomes and greater revenue loss relative to principal diagnosis: A retrospective cohort study
por: Zilberberg, Marya D., et al.
Publicado: (2018)

Examining the Burden of Potentially Avoidable Heart Failure Hospitalizations
por: Zilberberg, Marya D, et al.
Publicado: (2023)

Assessment of Reporting Bias for Clostridium difficile Hospitalizations, United States
por: Zilberberg, Marya D.
Publicado: (2008)

718 Predictors of Hospital Mortality Among Septic ICU Patients With Acinetobacter spp. Bacteremia: A Cohort Study
por: Shorr, Andrew F., et al.
Publicado: (2014)

Carbapenem Treatment and Outcomes Among Patients With Culture-Positive Complicated Intra-abdominal Infections in US Hospitals: A Retrospective Cohort Study
por: Zilberberg, Marya D, et al.
Publicado: (2019)

The risk of inappropriate empiric treatment and its outcomes based on pathogens in non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) bacterial pneumonia in the US, 2012–2019
por: Zilberberg, Marya D., et al.
Publicado: (2022)

30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study
por: Zilberberg, Marya D., et al.
Publicado: (2017)

1696. Epidemiology, Clinical Characteristics and Outcomes of Invasive Aspergillosis in a Tertiary Care Hospital in Mexico
por: Marina Román-Montes, Carla, et al.
Publicado: (2019)

681. Epidemiology and Outcomes of Patients with Carbapenem-Resistant Bloodstream Infection in United States Hospitals, 2010–2015
por: Echols, Roger, et al.
Publicado: (2018)

681. Epidemiology and Outcomes of Patients with Carbapenem-Resistant Bloodstream Infection in United States Hospitals, 2010–2015
por: Echols, Roger, et al.
Publicado: (2018)

1658 C. difficile Recurrence is a Strong Predictor of 30-day Rehospitalization Among ICU Patients
por: Zilberberg, Marya D., et al.
Publicado: (2014)

Gram-negative resistance and need for ICU among urinary tract infections in the United States
por: Zilberberg, M, et al.
Publicado: (2013)

987. Clinical Epidemiology and Outcomes of Invasive Pulmonary Aspergillosis as a Complication of Respiratory Viral Infection in Hospitalized Patients
por: De Los Santos, Bertha A, et al.
Publicado: (2021)

1461. Non-Invasive Pneumococcal Pneumonia in the United States, 2013–2014
por: Matanock, Almea, et al.
Publicado: (2018)

Current Epidemiology of Serogroup W Meningococcal Disease—United States, 2010–2015
por: Soeters, Heidi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_un3nn4ojm1oo933obcg9jb114n